Press release content from Business Wire. The AP news staff was not involved in its creation.
ConnectiveRx Strengthens Leadership
WHIPPANY, N.J. (BUSINESS WIRE) Jan 7, 2021
ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today announced the company is strengthening its leadership to support rapid growth with the appointment of David Wheadon, MD, as member of the company’s board of managers and Jim Corrigan as president.
“David and Jim have exceptional track records for leadership and strategic innovation in the pharmaceutical and greater healthcare sectors,” said ConnectiveRx CEO Harry Totonis. “Their addition to our organization enhances our ability to meet the evolving needs of our pharmaceutical manufacturer partners.”